Landscape Capital Management L.L.C. Has $592,000 Stake in The Chemours Company (NYSE:CC)

Landscape Capital Management L.L.C. grew its stake in shares of The Chemours Company (NYSE:CC) by 243.6% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 35,032 shares of the specialty chemicals company’s stock after buying an additional 24,837 shares during the period. Landscape Capital Management L.L.C.’s holdings in Chemours were worth $592,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. Strategic Financial Concepts LLC acquired a new position in Chemours in the fourth quarter worth about $357,000. Two Sigma Advisers LP boosted its holdings in Chemours by 9.4% during the third quarter. Two Sigma Advisers LP now owns 503,100 shares of the specialty chemicals company’s stock valued at $10,223,000 after purchasing an additional 43,200 shares in the last quarter. Entropy Technologies LP bought a new stake in shares of Chemours in the 4th quarter valued at approximately $266,000. Twelve Points Wealth Management LLC lifted its position in shares of Chemours by 42.8% during the 4th quarter. Twelve Points Wealth Management LLC now owns 78,325 shares of the specialty chemicals company’s stock worth $1,324,000 after buying an additional 23,490 shares during the period. Finally, Sei Investments Co. lifted its position in shares of Chemours by 779.5% during the 4th quarter. Sei Investments Co. now owns 174,555 shares of the specialty chemicals company’s stock worth $2,950,000 after buying an additional 154,709 shares during the period. Institutional investors own 76.26% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have commented on CC. Morgan Stanley reduced their price target on shares of Chemours from $25.00 to $22.00 and set an “equal weight” rating on the stock in a research report on Monday, January 13th. The Goldman Sachs Group reduced their target price on Chemours from $24.00 to $21.00 and set a “neutral” rating on the stock in a report on Tuesday, January 7th. BMO Capital Markets reduced their price target on shares of Chemours from $34.00 to $27.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 19th. Mizuho upgraded shares of Chemours from a “neutral” rating to an “outperform” rating and set a $19.00 price objective for the company in a research report on Thursday, March 27th. Finally, Truist Financial started coverage on shares of Chemours in a research report on Tuesday, January 28th. They set a “buy” rating and a $27.00 target price on the stock. Four investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, Chemours has an average rating of “Moderate Buy” and a consensus price target of $22.56.

Chemours Stock Performance

Shares of Chemours stock opened at $10.61 on Monday. The firm has a fifty day moving average of $15.67 and a two-hundred day moving average of $18.01. The company has a debt-to-equity ratio of 6.70, a quick ratio of 0.92 and a current ratio of 1.68. The stock has a market capitalization of $1.58 billion, a price-to-earnings ratio of 18.61 and a beta of 1.84. The Chemours Company has a 52 week low of $10.12 and a 52 week high of $29.21.

Chemours (NYSE:CC) last issued its earnings results on Tuesday, February 18th. The specialty chemicals company reported $0.11 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.10 by $0.01. Chemours had a return on equity of 26.54% and a net margin of 1.51%. The firm had revenue of $1.36 billion for the quarter, compared to analysts’ expectations of $1.37 billion. As a group, equities research analysts predict that The Chemours Company will post 2.03 EPS for the current year.

Chemours Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Friday, February 28th were issued a dividend of $0.25 per share. The ex-dividend date was Friday, February 28th. This represents a $1.00 annualized dividend and a yield of 9.43%. Chemours’s dividend payout ratio is presently 175.44%.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.